The prognostic capacity of B-type natriuretic peptide on cognitive disorder varies by age

Annals of Medicine

Volumn 45, Issue 1, 2013, Pages 74-78

  Hiltunen, Matti ^a,b   Kerola, Tuomas ^b   Kettunen, Raimo ^b   Hartikainen, Sirpa ^c,d   Sulkava, Raimo ^c,e   Vuolteenaho, Olli ^f   Nieminen, Tuomo ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d Leppavirta Health Centre   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF OULU   (Finland)

Author keywords

Cardiovascular burden; Cognitive disorder; Cognitive impairment; Dementia; Natriuretic peptides; Older people

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGE DISTRIBUTION; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ATRIAL NATRIURETIC FACTOR; CASE-CONTROL STUDIES; COGNITION DISORDERS; DEMENTIA, VASCULAR; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84872183171     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2012.663929     Document Type: Article

References (23)

1. Kerola T, Kettunen R 1., Nieminen T. Th e complex interplay of cardiovascular system and cognition: How to predict dementia in the elderly? Int J Cardiol. 2011;150:123-9.
2. Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol. 2008;585:97-108.
3. Vuolteenaho O, Ala-Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease. Adv Clin Chem. 2005;40:1-36. (Pubitemid 43588719)
4. Buerger K, Ernst A, Ewers M, Uspenskaya O, Omerovic M, Morgenthaler NG, et al. Blood-based microcirculation markers in Alzheimer ' s disease-diagnostic value of midregional pro-atrial natriuretic peptide/ C-terminal endothelin-1 precursor fragment ratio. Biol Psychiatry. 2009;65:979-84.
5. Kerola T, Nieminen T, Hartikainen S, Sulkava R, Vuolteenaho O, Kettunen R. B-type natriuretic peptide as a predictor of declining cognitive function and dementia-a cohort study of an elderly general population with a 5-year follow-up. Ann Med. 2010;42:207-15.
6. Feola M, Rosso GL, Peano M, Agostini M, Aspromonte N, Carena G, et al. Correlation between cognitive impairment and prognostic parameters in patients with congestive heart failure. Arch Med Res. 2007;38:234-9. (Pubitemid 46080551)
7. Gunstad J, Poppas A, Smeal S, Paul RH, Tate DF, Jeff erson AL, et al. Relation of brain natriuretic peptide levels to cognitive dysfunction in adults - 55 years of age with cardiovascular disease. American J Cardiol. 2006;98:538- 40.
8. Naito J, Naka Y, Watanabe H. Clinical impression of brain natriuretic peptide levels in demented patients without cardiovascular disease. Geriatr Gerontol Int. 2009;9:242-5.
9. Kondziella D, Gothlin M, Fu M, Zetterberg H, Wallin A. B-type natriuretic peptide plasma levels are elevated in subcortical vascular dementia. Neuroreport. 2009;20:825-7.
10. Redfi eld MM, Rodeheff er RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976-82. (Pubitemid 34994995)
11. Buerger K, Uspenskaya O, Hartmann O, Hansson O, Minthon L, Blennow K, et al. Prediction of Alzheimer ' s disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: A retrospective analysis of 134 patients with mild cognitive impairment. J Clin Psychiatry. 2011;72:556-63.
12. Luchner A, Burnett J.C. Jougasaki M, Hense HW, Heid IM, Muders F, et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population. J Hypertens. 2000;18:1121-8.
13. Sayama H, Nakamura Y, Saito N, Kinoshita M. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron Artery Dis. 1999;10:537-40. (Pubitemid 30011913)
14. Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM. Natriuretic peptides: Their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol. 2009:341-66.
15. Alehagen U, Svensson E, Dahlstrom U. Natriuretic peptide biomarkers as information indicators in elderly patients with possible heart failure followed over six years: A head-to-head comparison of four cardiac natriuretic peptides. J Card Fail. 2007;13:452-61. (Pubitemid 47176924)
16. Bhandari SS, Davies JE, Struck J, Ng LL. Infl uence of confounding factors on plasma mid-regional pro-adrenomedullin and mid-regional pro-A-type natriuretic peptide concentrations in healthy individuals. Biomarkers. 2011;16:281-7.
17. Loke I, Squire IB, Davies JE, Ng LL. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail. 2003;5:599-606. (Pubitemid 38043963)
18. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev. 2003;24:341- 56. (Pubitemid 36724374)
19. Abassi Z, Karram T, Ellaham S, Winaver J, Hoff man A. Implications of the natriuretic peptide system in the pathogenesis of heart failure: Diagnostic and therapeutic importance. Pharmacol Th er. 2004;102: 223-41. (Pubitemid 38887694)
20. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PW, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: The Framingham heart study. JAMA. 2002;288:1252-9. (Pubitemid 35001328)
21. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998;351:9- 13. (Pubitemid 28020159)
22. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 1996;28:988-94. (Pubitemid 26415815)
23. Ala-Kopsala M, Ruskoaho H, Leppaluoto J, Seres L, Skoumal R, Toth M, et al. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides. Clin Chem. 2005;51:708-18. (Pubitemid 40463922)